ALK Financial Statements From 2010 to 2025
| ALK-B Stock | DKK 145.00 0.70 0.49% |
Check ALK Abell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ALK Abell's main balance sheet or income statement drivers, such as , as well as many indicators such as . ALK financial statements analysis is a perfect complement when working with ALK Abell Valuation or Volatility modules.
ALK |
ALK Abell AS Company Current Valuation Analysis
ALK Abell's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ALK Abell Current Valuation | 23.1 B |
Most of ALK Abell's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ALK Abell AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ALK Abell AS has a Current Valuation of 23.1 B. This is 60.81% higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The current valuation for all Denmark stocks is 38.94% lower than that of the firm.
ALK Abell AS Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ALK Abell's current stock value. Our valuation model uses many indicators to compare ALK Abell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ALK Abell competition to find correlations between indicators driving ALK Abell's intrinsic value. More Info.ALK Abell AS is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ALK Abell AS is roughly 1.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ALK Abell by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ALK Abell's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About ALK Abell Financial Statements
ALK Abell stakeholders use historical fundamental indicators, such as ALK Abell's revenue or net income, to determine how well the company is positioned to perform in the future. Although ALK Abell investors may analyze each financial statement separately, they are all interrelated. For example, changes in ALK Abell's assets and liabilities are reflected in the revenues and expenses on ALK Abell's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ALK Abell AS. Please read more on our technical analysis and fundamental analysis pages.
ALK-Abell AS, a pharmaceutical company, develops and markets products and services for allergy and allergic asthma in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. ALK Abell operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 2379 people.
Pair Trading with ALK Abell
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ALK Abell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will appreciate offsetting losses from the drop in the long position's value.Moving together with ALK Stock
Moving against ALK Stock
| 0.65 | GRLA | Groenlandsbanken | PairCorr |
| 0.65 | DONKEY | Donkeyrepublic Holding | PairCorr |
| 0.62 | JYSK | Jyske Bank AS | PairCorr |
| 0.6 | SCHO | Schouw | PairCorr |
| 0.58 | NDA-DK | Nordea Bank Abp | PairCorr |
The ability to find closely correlated positions to ALK Abell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ALK Abell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ALK Abell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ALK Abell AS to buy it.
The correlation of ALK Abell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ALK Abell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ALK Abell AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ALK Abell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ALK Stock
ALK Abell financial ratios help investors to determine whether ALK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALK with respect to the benefits of owning ALK Abell security.